MedTrace Logo

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

NCT01336907 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-09-21

No results posted yet for this study

Summary

The FORESEE HOME is intended for the early detection of central and paracentral irregularities (abnormalities) in the visual field, most commonly associated with Age Related Macular Degeneration (AMD). However, the device has the ability to detect the development of the lesion post treatment and therefore to assess in determination of the next treatment.

The Optical Coherence Tomography (OCT) may be used as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices.

The FORESEE HOME can be used as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluating the size and the location of the treated lesions may serve as an additional tool.

Conditions

  • Age Related Macular Degeneration
  • Choroidal Neovascularization

Sponsors & Collaborators

  • Notal Vision Ltd.

    lead INDUSTRY

Principal Investigators

  • Giuseppe Querques, Dr. · Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil, University Paris XII, Paris, France

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01336907 on ClinicalTrials.gov